ORMP - Oramed Pharmaceuticals Inc.
NEXT EARNINGS:
Mar 26, 2026
(in 29 days)
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
Market Cap:
137.87M
Volume:
144,372
Avg Volume:
237,720
52 Week Range:
1.82-3.71
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.31
Last Dividend:
$0.25
Exchange:
NASDAQ
Country:
US
Employees:
13
IPO Date:
2007-05-01
EPS (TTM):
-0.47
P/E Ratio:
-5.17
Revenue (TTM):
N/A
Total Assets:
155.28M
Total Debt:
372,000
Cash & Equiv:
54.42M
Rev Growth (5Y):
-100.0%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-10.1%
Debt/Equity:
0.00
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-13 | $1.13 | $-0.04 | +2925.0% | — | — | — |
| 2025-08-14 | $-0.05 | $-0.04 | -25.0% | — | — | — |
| 2025-05-15 | $-0.19 | $-0.03 | -533.3% | $2.0M | — | — |
| 2025-03-27 | $0.01 | $-0.03 | +133.3% | — | — | — |
| 2024-11-07 | $-0.48 | $-0.00 | -9695.9% | — | — | — |
| 2024-08-14 | $0.26 | $0.01 | +2500.0% | — | $250000 | — |
| 2024-05-09 | $0.04 | $0.02 | +100.0% | — | $500000 | — |
| 2024-03-06 | $-0.08 | $-0.12 | +33.3% | — | — | — |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0 | 1.34M | 2.70M | 2.70M | 2.71M | 2.70M | 2.45M | 2.46M | 641,000 | 0 | 0 | 0 |
| Net Income | (19.10M) | 5.53M | (37.76M) | (22.24M) | (11.51M) | (14.36M) | (12.73M) | (10.48M) | (10.96M) | (7.23M) | (5.70M) | (4.23M) |
| EPS | -0.47 | 0.14 | -0.97 | -0.78 | -0.56 | -0.82 | -0.86 | -0.79 | -0.87 | -0.67 | -0.62 | -0.59 |
| Total Assets | 155.28M | 220.55M | 161.64M | 128.00M | 44.63M | 34.66M | 47.40M | 38.71M | 42.83M | 26.35M | 21.80M | 8.66M |
| Total Debt | 372,000 | 51.62M | 894,000 | 533,000 | 75,000 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash & Equivalents | 54.42M | 9.05M | 40.46M | 77.25M | 19.30M | 3.33M | 5.00M | 3.97M | 3.91M | 3.21M | 1.76M | 2.27M |
| Operating Cash Flow | (8.41M) | (10.29M) | (27.92M) | (21.18M) | (12.44M) | (12.94M) | (14.66M) | (5.83M) | 4.66M | (4.95M) | (4.07M) | (3.40M) |
| Free Cash Flow | (8.43M) | (10.55M) | (28.41M) | (21.56M) | (12.52M) | (12.96M) | (14.66M) | (5.84M) | 4.65M | (4.95M) | (4.08M) | (3.40M) |
| FCF per Share | -0.21 | -0.26 | -0.73 | -0.76 | -0.61 | -0.74 | -0.99 | -0.44 | 0.37 | -0.46 | -0.44 | -0.47 |
| Book Value | 146.26M | 163.82M | 151.81M | 115.77M | 32.88M | 19.39M | 31.11M | 19.24M | 26.19M | 24.83M | 20.79M | 8.13M |
| Cash & ST Investments | 141.93M | 162.05M | 155.72M | 94.14M | 39.90M | 32.28M | 30.46M | 20.12M | 31.02M | 17.23M | 21.29M | 8.48M |
| ROC Equity | -0.13 | 0.03 | -0.25 | -0.19 | -0.35 | -0.74 | -0.41 | -0.54 | -0.42 | -0.29 | -0.27 | -0.52 |